US Stock MarketDetailed Quotes

JANX Janux Therapeutics

Watchlist
  • 53.920
  • +0.680+1.28%
Close Jan 3 16:00 ET
  • 54.100
  • +0.180+0.33%
Post 20:01 ET
3.16BMarket Cap-46.09P/E (TTM)

Janux Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Janux Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.211M--
--2024/Q4-- / 490.000K--
--2024/Q3439.000K / 1.645M--
--2024/Q28.897M / 863.120K--
--2024/Q11.252M / 1.018M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.211M--
--2024/Q4-- / 490.000K--
--2024/Q3439.000K / 1.645M--
--2024/Q28.897M / 863.120K--
--2024/Q11.252M / 1.018M--

Unlock Free Earnings Estimates

Janux Therapeutics Earnings Reports

  • Janux Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 6, 2024 16:29 ET

  • Janux Therapeutics | 8-K: Janux Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights

    Nov 6, 2024 16:15 ET

  • Janux Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 7, 2024 22:24 ET

  • Janux Therapeutics | 8-K: Janux Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights

    Aug 7, 2024 16:28 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 4, 2025

    Strong Buy

    • Buy

      91.67%

    • Hold

      8.33%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data